177 related articles for article (PubMed ID: 7538713)
41. [Interstitial laser coagulation of benign prostatic hyperplasia].
Muschter R; Hessel S; Hofstetter A; Keiditsch E; Rothenberger KH; Schneede P; Frank F
Urologe A; 1993 Jul; 32(4):273-81. PubMed ID: 7690498
[TBL] [Abstract][Full Text] [Related]
42. [Acute urinary retention in the benign prostatic syndrome].
Gratzke C; Reich O; Bachmann A; Seitz M; Stief CG
MMW Fortschr Med; 2005 Oct; 147(41):45. PubMed ID: 16270512
[No Abstract] [Full Text] [Related]
43. [Role of blood supply disturbance and tissue hypoxia in the development of bladder dysfunction in bladder outlet obstruction caused by the prostatic adenoma].
Kirpatovskiĭ VI; Sivkov AV; Fediakov RP; Khromov RA; Bablumian AIu; Nadtochiĭ ON
Urologiia; 2013; (2):123-8. PubMed ID: 23789378
[No Abstract] [Full Text] [Related]
44. Quantification of voiding dysfunction in patients awaiting transurethral prostatectomy.
Javlé P; Jenkins SA; West C; Parsons KF
J Urol; 1996 Sep; 156(3):1014-8; discussion 1018-9. PubMed ID: 8709299
[TBL] [Abstract][Full Text] [Related]
45. Benign prostatic obstruction and parkinson's disease--should transurethral resection of the prostate be avoided?
Roth B; Studer UE; Fowler CJ; Kessler TM
J Urol; 2009 May; 181(5):2209-13. PubMed ID: 19296974
[TBL] [Abstract][Full Text] [Related]
46. Study of detrusor dysfunction due to outlet obstruction: link between analysis of uroflows of men with benign prostatic hyperplasia and animal studies.
Valentini FA; Levin RM; Besson GR; Nelson PP
Adv Exp Med Biol; 2003; 539(Pt A):297-309. PubMed ID: 15088913
[No Abstract] [Full Text] [Related]
47. Contemporary management of the benign obstructive prostate: an overview.
Malek RS
Mayo Clin Proc; 1998 Jun; 73(6):589. PubMed ID: 9621868
[No Abstract] [Full Text] [Related]
48. Estimation of urethral resistance by curve fitting in the pressure-flow plot. Theory and experience in normal men and men with benign prostatic hypertrophy.
Spångberg A
World J Urol; 1995; 13(1):65-9. PubMed ID: 7539681
[TBL] [Abstract][Full Text] [Related]
49. Prostate artery embolisation for benign prostatic hyperplasia.
Challacombe B; Sabharwal T
BMJ; 2018 Jun; 361():k2537. PubMed ID: 29921580
[No Abstract] [Full Text] [Related]
50. [Criteria for severity of prostatic hyperplasia and the treatment efficacy].
Masumori N; Tsukamoto T
Nihon Rinsho; 2002 Dec; 60 Suppl 11():322-6. PubMed ID: 12599593
[No Abstract] [Full Text] [Related]
51. Making the diagnosis of benign prostatic hyperplasia. A critical review.
el Din KE; Debruyne FM; de la Rosette JJ
Eur Urol; 1997; 31(3):257-62. PubMed ID: 9129913
[No Abstract] [Full Text] [Related]
52. Prostatic and bladder neck syndromes--2. Bladder neck obstruction.
Smith P
Nurs Times; 1978 Jun; 74(24):1007-9. PubMed ID: 79172
[No Abstract] [Full Text] [Related]
53. Taming the overgrown prostate.
Willis D
Am J Nurs; 1992 Feb; 92(2):34-40. PubMed ID: 1371203
[No Abstract] [Full Text] [Related]
54. Alternative methods for management of prostatic outflow obstruction.
Donatucci CF
Curr Opin Urol; 1999 Jan; 9(1):39-44. PubMed ID: 10726070
[TBL] [Abstract][Full Text] [Related]
55. Effect of hydroxyprogesterone caproate on experimental benign prostatic obstruction in the mouse.
Caine M; Superstine E
Isr J Med Sci; 1973; 9(11):1559-64. PubMed ID: 4130461
[No Abstract] [Full Text] [Related]
56. Editorial: benign prostatic hyperplasia.
Djavan B
Curr Opin Urol; 2013 Jan; 23(1):1. PubMed ID: 23202284
[No Abstract] [Full Text] [Related]
57. Correlations between urethral elastance and histological architecture in patients with benign prostatic hyperplasia.
Ichiyanagi O; Sasagawa I; Aoyama N; Ishigooka M; Kubota Y; Nakada T
Scand J Urol Nephrol; 1998 May; 32(3):215-8. PubMed ID: 9689702
[TBL] [Abstract][Full Text] [Related]
58. [Role of the prostatic capsule in the physiopathology of benign prostatic hypertrophy].
Sattar AA; Caufriez M; Wespes E; Noël JC; Schulman CC
Acta Urol Belg; 1994 Sep; 62(3):43-6. PubMed ID: 7526669
[No Abstract] [Full Text] [Related]
59. A multivariate analysis of lower urinary tract ageing and urinary symptoms: the role of fibrosis.
Bercovich E; Barabino G; Pirozzi-Farina F; Deriu M
Arch Ital Urol Androl; 1999 Dec; 71(5):287-92. PubMed ID: 10673792
[TBL] [Abstract][Full Text] [Related]
60. Pre treatment decision making in prostatism--a stochastic analysis based on the most used diagnostic tests.
Zdanowski A; Hansen MV
Scand J Urol Nephrol; 1995 Jun; 29(2):173-81. PubMed ID: 7569795
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
